相关实验视频
Updated: Jan 31, 2026

13:10
Use of Alu Element Containing Minigenes to Analyze Circular RNAs
Published on: March 10, 2020
7.7K
结直肠瘤发生中的癌症干度调节圆形RNA:点蛋白和调节机制
Chiu-Jung Huang1, Kong Bung Choo2
1Department of Animal Science & Graduate Institute of Biotechnology, College of Environmental Planning & Bioresources (former School of Agriculture), Chinese Culture University, Taipei, 11114, Taiwan.
Biochemical and biophysical research communications
|January 29, 2026
概括
循环RNAs (circRNAs) 调节癌症的干细胞性. 本综述在结直肠癌中确定了14种癌症干度调节circRNAs (CSM-circRNAs),突出了它们的诊断和治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 癌症干细胞 (CSCs) 驱动瘤生长和复发.
- 循环RNAs (circRNAs) 越来越多地被认为是癌症干的关键调节者.
研究的目的:
- 在结直肠癌 (CRC) 中系统地审查和定义癌症干度调节circRNAs (CSM-circRNAs).
- 阐明CSM-circRNAs在CRC进展中的机制和功能作用.
主要方法:
- 系统的文献审查,严格的选择标准.
- 使用球形形成试验和茎度标记物表达,验证已识别的CSM-circRNAs.
- 调节机制 (miRNA海绵,RNA结合蛋白相互作用) 和下游蛋白质点的分析.
主要成果:
- 在CRC中发现了14个失调的CSM-circRNA,其中大多数是上调的,许多显示泛癌失调.
- CSM-circRNAs调节关键的CSC特征,主要是通过miRNA海绵或RNA结合蛋白相互作用.
- 失调的CSM-circRNA调节蛋白质会影响多种癌症类型的关键信号通路.
结论:
- CSM-circRNAs代表了一种新型的转录后调节器类,可促进CRC的癌症干和恶性进展.
- CSM-circRNAs对结直肠癌具有显著的诊断和治疗潜力.
- 对功能性circRNAs进行分类的系统框架可以帮助研究各种疾病.
相关概念视频
lncRNA - Long Non-coding RNAs
9.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.9K
piRNA - Piwi-interacting RNAs
7.6K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.6K
siRNA - Small Interfering RNAs
18.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.6K
Mechanical Protein Functions
5.6K
Proteins perform many mechanical functions in a cell. These proteins can be classified into two general categories- proteins that generate mechanical forces and proteins that are subjected to mechanical forces. Proteins providing mechanical support to the structure of the cell, such as keratin, are subjected to mechanical force, whereas proteins involved in cell movement and transport of molecules across cell membranes, such as an ion pump, are examples of generating mechanical force.
5.6K
Cis-regulatory Sequences
11.8K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.8K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K

